Investor Presentation - August 2016
Fineotex Chemical Ltd has submitted to BSE a copy of "Investor Presentation - August 2016"22-08-2016
Investor Presentation - August 2016
Fineotex Chemical Ltd has submitted to BSE a copy of "Investor Presentation - August 2016"Earning Presentation for June 30, 2016
Fineotex Chemical Ltd has submitted to BSE a copy of Earning Presentation for quarter ended 30th June 2016.Intimation of Conference Call
Fineotex Chemical Ltd has informed BSE regarding "Intimation of Conference Call".Standalone & Consolidated Financial Results, Limited Review Report for June 30, 2016
Fineotex Chemical Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 20164. Consolidated Limited Review for the period ended June 30, 2016Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Amitabh Harivanshrai Bachchan has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Board Meeting Intimation for Results
Fineotex Chemical Ltd has informed BSE that the meeting of the Board of directors of the Company is convened on August 13, 2016, to consider and approve the un-audited financial results for the quarter ended June 30, 2016.Closure of Trading Window
Fineotex Chemical Ltd has informed BSE regarding "Closure of Trading Window".Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Fineotex Chemical Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Details of Analyst / Investor Meet
Fineotex Chemical Ltd has informed BSE regarding "Details of Analyst / Investor Meet"Intimation of Schedule of Analyst / Institutional Investor Meetings
Fineotex Chemical Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings"